- HER2 negative
- ER positive
- HER2 positive
- PD-L1 positive
- PR positive
- PR negative
- ER negative
- p16 positive
- KRAS positive
- EGFR positive
- PD-L1 negative
- EGFR negative
- BRAF positive
- ALK negative
- HLA-A positive
- BRCA1 positive
- BRCA2 positive
- CD20 positive
- MET positive
- IDH positive
- ALK positive
- CD19 positive
- p16 negative
- HLA positive
- IDH negative
- HPV positive
- MYC positive
- PALB2 positive
- ROS1 positive
- ROS1 negative
- BRAF negative
- HLA negative
- MSI-H positive
- NRAS positive
- PIK3CA positive
- RET positive
- HLA-A negative
- HR positive
- MET negative
- RB1 negative
- RB1 positive
- TP53 positive
- dMMR positive
- BRCA positive
- HPV negative
- KIT positive
- ARID1A positive
- Bcl2 positive
- MGMT negative
- RAS positive
- CCND1 positive
- KRAS negative
- MMR positive
- NTRK positive
- ATM positive
- BCL6 positive
- FLT3 positive
- MGMT positive
- NF1 positive
- PTEN positive
- ANA positive
- BRIP1 positive
- CD30 positive
- CFTR positive
- CHEK2 positive
- HBsAg positive
- HRAS positive
- MLH1 positive
- MSH2 positive
- MSH6 positive
- NRAS negative
- PD-1 positive
- PMS2 positive
- RAD51 positive
- TP53 negative
- Anti-dsDNA positive
- FANCA positive
- HPV16 positive
- HR negative
- HbSS positive
- MMR negative
- NTRK1 positive
- PD-1 negative
- RET negative
- RF positive
- TROP2 positive
- ABCA4 positive
- BARD1 positive
- BCR-ABL1 positive
- BRCA negative
- BRCA1 negative
- BRCA2 negative
- CD123 positive
- CD3 positive
- DLL3 positive
- FMR1 positive
- GRN positive
- HBV DNA negative
- HBsAg negative
- Ki-67 positive
- MECP2 positive
- MSI negative
- MSI positive
- MSI-H negative
- MSS negative
- NF2 positive
- Ras negative
- SMN1 positive
- TROP2 negative
- ctDNA positive
- dMMR negative
- p53 positive
- t(11;14) positive
- t(14;16) positive
- t(4;14) positive
- AKT1 positive
- APOL1 positive
- AR positive
- BAP1 positive
- C5 positive
- CD19 negative
- CD22 positive
- CD33 positive
- CD4 positive
- CD5 positive
- CD8 positive
- CDK12 positive
- CLDN18.2 positive
- CTNNB1 positive
- DMPK positive
- FGFR positive
- FGFR2 positive
- GPC3 positive
- HBV DNA positive
- IAA positive
- KMT2A positive
- PDGFRA positive
- PIK3CA negative
- PTEN negative
- Ph positive
- Philadelphia chromosome positive
- RAF positive
- SMARCB1 positive
- SMN2 positive
- STK11 positive
- TERT positive
- TMB positive
- ZnT8 positive
- anti-AChR positive
- anti-Ro autoantibodies positive
- del(17p) positive
- t(14;20) positive
- AChR positive
- AKT negative
- APC positive
- APOE negative
- APOE positive
- APP positive
- ASXL1 positive
- ATR positive
- BCR::ABL1 positive
- CA-125 positive
- CCNE1 positive
- CD10 positive
- CD30 negative
- CD4 count positive
- CD70 positive
- CDK4 positive
- CHEK1 positive
- COL7A1 positive
- CRLF2 positive
- Complex karyotype positive
- DGM7 positive
- DMD positive
- DNMT3A positive
- EBV positive
- EPCAM positive
- Ex19del positive
- FANCC positive
- FANCD2 positive
- FANCG positive
- FANCL positive
- FAP positive
- FGFR3 positive
- FH positive
- FLT3 negative
- FOXO1 fusion negative
- G719X positive
- H3 K27M positive
- HBB positive
- HBcAb negative
- HBeAg positive
- HRD positive
- HRRm positive
- HbSβ0-thalassemia positive
- IA-2 positive
- IA-2A positive
- ICA positive
- ICOS positive
- IL2RG positive
- Gleason Score 10
- Gleason Score 7
- Gleason Score 8
- Gleason Score 9
- Grade 1
- Grade 2
- Grade 3
- Grade 4
- Stage IV
- Stage III
- Stage II
- Stage I
- 1927nm Fractional Thulium Laser Treatment
- Adjuvant Chemotherapy without Concurrent Biologic/Targeted Therapy
- Adjuvant Therapy (except reconstruction)
- Alopecia from Prior Anti-Cancer Therapy
- Anemia from Prior Anti-Cancer Therapy
- Anti-Seizure Medications (up to 2 types)
- Antibody-Based Therapy
- Antifibrotic Medications (Nintedanib, Pirfenidone)
- Any Prior Treatment
- Any Treatment for Pancreatic Cancer
Trial Status
Recruiting statusPlacebo
Recruiting
Waitlist Available
Administration Type
Trial Phase
Biomarkers
Stage of Disease
5615 trials
Trials Without a Placebo
1
2
3
…50